US Patent 10220090 BCMA Antigen binding proteins
Patent 10220090 was granted and assigned to Amgen on March, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10220090 BCMA Antigen binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.